”Interferon is a type of protein that is produced by the body's immune system in response to viral infections. It has been used as a treatment for certain types of cancer, including leukemia and lymphoma. While interferon therapy can help reduce the size of tumors and the number of cancer cells in the body, it is not always able to achieve a complete molecular response (CMR). A complete molecular response is when the cancer cells can not be detected by molecular test.Some studies have suggested that the use of interferon in combination with other treatments may help to increase the chances of achieving a complete molecular response. However, the response rate varies depending on the type of cancer, stage of the disease and other factors. It's worth noting that achieving CMR is not common in most cancer types, and it's considered a challenging task”
Interferon and CMR according to ChatGPT - MPN Voice
Interferon and CMR according to ChatGPT
Written by
Manouche
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
My experience with InterferonManouche so many pepole have a positive experience, however there are many others who find the medine not particularly effective and in my own case hard to take. The effects and side effects for me were like a chemical kosher and lm still struggling with the effects. At times l feel so physically and emotionally low and feel like lm running out of options. There are some good papers on this med and you can access them here.
we are all so very diffrent good luck with finding those meds that work for you.
Not what you're looking for?
You may also like...
More INF reports, PEG vs Besremi, CMR vs progression
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421384/
CMR: Complete molecular response, PMR:...
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
« Patients with PV often have high JAK2 V 617F VAF (>50%) because of the emergence of a dominant...
Molecular Response vs progression, Rux
A long term study looked at molecular response (MR) vs progression for PV and ET. It was for Rux...
“Interferon” with MPN hematopoietic stem cells
« In this issue of Blood, Rao et al reveal important insights into how hematopoietic stem cell...
INTERFERON-ALPHA TREATMENT RESULTS IN THE DEPLETION OF DORMANT JAK2-MUTANT HSC IN A MURINE MODEL OF POLYCYTHEMIA VERA
« The majority of patients with Bcr-Abl negative myeloproliferative neoplasms (MPN) have a...